Authors:
BRUISTEN SM
REISS P
LOELIGER AE
VANSWIETEN P
SCHUURMAN R
BOUCHER CAB
WEVERLING GJ
HUISMAN JG
Citation: Sm. Bruisten et al., CELLULAR PROVIRAL HIV TYPE-1 DNA LOAD PERSISTS AFTER LONG-TERM RT-INHIBITOR THERAPY IN HIV TYPE-1 INFECTED PERSONS, AIDS research and human retroviruses, 14(12), 1998, pp. 1053-1058
Authors:
BRUISTEN SM
FRISSEN PHJ
VANSWIETEN P
HARRIGAN PR
KINGHORN I
LARDER B
WEIGEL HM
DEVRIES E
REGEZ RM
HENRICHS JH
KOOT M
HUISMAN JG
Citation: Sm. Bruisten et al., PROSPECTIVE LONGITUDINAL ANALYSIS OF VIRAL LOAD AND SURROGATE MARKERSIN RELATION TO CLINICAL PROGRESSION IN HIV TYPE 1-INFECTED PERSONS, AIDS research and human retroviruses, 13(4), 1997, pp. 327-335
Authors:
BRUISTEN SM
OUDSHOORN P
VANSWIETEN P
BOESERNUNNINK B
VANAARLE P
TONDREAU SP
CUYPERS HTM
Citation: Sm. Bruisten et al., STABILITY OF HIV-1 RNA IN BLOOD DURING SPECIMEN HANDLING AND STORAGE PRIOR TO AMPLIFICATION BY NASBA-QT, Journal of virological methods, 67(2), 1997, pp. 199-207
Authors:
GROENEVELD PHP
KROON FP
NIBBERING PH
BRUISTEN SM
VANSWIETEN P
VANFURTH R
Citation: Php. Groeneveld et al., INCREASED PRODUCTION OF NITRIC-OXIDE CORRELATES WITH VIRAL LOAD AND ACTIVATION OF MONONUCLEAR PHAGOCYTES IN HIV-INFECTED PATIENTS, Scandinavian journal of infectious diseases, 28(4), 1996, pp. 341-345
Authors:
VANMILLIGEN FJ
CRAIG S
ROGERS BL
VANSWIETEN P
AALBERSE RC
Citation: Fj. Vanmilligen et al., DIFFERENCES BETWEEN SPECIFICITIES OF IGE AND IGG4 ANTIBODIES - STUDIES USING RECOMBINANT CHAIN-1 AND CHAIN-2 OF THE MAJOR CAT ALLERGEN FELIS-DOMESTICUS (FEL-D)-I, Clinical and experimental allergy, 25(3), 1995, pp. 247-251
Authors:
BRUISTEN S
FRISSEN J
HUISMAN J
WEIGEL H
VANSWIETEN P
DEVRIES E
REGEZ R
HARRIGAN R
TERSMETTE M
REISS P
Citation: S. Bruisten et al., VIRAL LOAD AND SURROGATE MARKERS IN A PROSPECTIVE-STUDY OF ASYMPTOMATIC HIV-1-INFECTED PERSONS, Journal of cellular biochemistry, 1995, pp. 202-202
Authors:
STRINGER HAR
VANSWIETEN P
HEIJNEN HFG
SIXMA JJ
PANNEKOEK H
Citation: Har. Stringer et al., PLASMINOGEN-ACTIVATOR INHIBITOR-1 RELEASED FROM ACTIVATED PLATELETS PLAYS A KEY ROLE IN THROMBOLYSIS RESISTANCE - STUDIES WITH THROMBI GENERATED IN THE CHANDLER LOOP, Arteriosclerosis and thrombosis, 14(9), 1994, pp. 1452-1458
Authors:
STRINGER HAR
VANSWIETEN P
HORREVOETS AJG
SMILDE A
PANNEKOEK H
Citation: Har. Stringer et al., THE ROLE OF THE FINGER DOMAIN OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN INITIATION AND PROGRESSION OF THROMBOLYSIS, Thrombosis and haemostasis, 72(6), 1994, pp. 900-905
Citation: Fj. Vanmilligen et al., IGE AND IGG4 BINDING TO THE OCELOT VARIANT OF THE CAT (FELIS-DOMESTICUS) MAJOR ALLERGEN FEL-D-I, Allergy, 49(5), 1994, pp. 393-394
Authors:
STRINGER HAR
VANSWIETEN P
HEIJNEN HFG
SIXMA JJ
PANNEKOEK H
Citation: Har. Stringer et al., ON THE FUNCTION OF PAI-1 IN PLATELET-RICH THROMBI PRODUCED IN THE CHANDLER LOOP, Thrombosis and haemostasis, 69(6), 1993, pp. 582-582